Search Results - "Lubik, S"

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study by Graf, M, Ecker, D, Horowski, R, Kramer, B, Riederer, P, Gerlach, M, Hager, C, Ludolph, A C, Becker, G, Osterhage, J, Jost, W H, Schrank, B, Stein, C, Kostopulos, P, Lubik, S, Wekwerth, K, Dengler, R, Troeger, M, Wuerz, A, Hoge, A, Schrader, C, Schimke, N, Krampfl, K, Petri, S, Zierz, S, Eger, K, Neudecker, S, Traufeller, K, Sievert, M, Neundörfer, B, Hecht, M

“…Increasing evidence has suggested that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). The antioxidant vitamin E…”
Get full text

Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation by Lubik, S, Fogel, W, Tronnier, V, Krause, M, König, J, Jost, W H

“…The aim of our study was to observe the effects on gait parameters induced by STN stimulation and levodopa medication in patients with advanced Parkinson's…”
Get full text

Process-based vs. product-based innovation: Value creation by nanotech ventures by Maine, Elicia, Lubik, Sarah, Garnsey, Elizabeth

“…Nanotechnology is frequently heralded as the next wave of technological advance, poised to enable radical innovation across many industries. But as yet little…”
Get full text

Overcoming commercialization challenges in science-based business: Strategies for advanced materials ventures by Maine, E., Lubik, S., Garnsey, E.

“…Science-based businesses have become the main drivers of commercialization for radical technological advances, but face high technology uncertainty over long…”
Get full text

Beyond niche thinking: Market selection in science-based ventures by Lubik, S., Garnsey, E., Minshall, T.

“…Matching a new technology to an appropriate market is a major challenge for new technology-based firms (NTBF). Such firms are often advised to target…”
Get full text